For context, I have severe ME (housebound, not bedbound) and am/was a Speech & Language Therapist.
I like the idea of trying to see what, if anything, works, out of all of the management advice that is currently given. And what might do harm.
I would vote for doing these trials with people with moderate ME. If something looks like it might help those with moderate ME, to a disability-reducing extent, then we could think about a trial with severe/very severe patients.
I appreciate the desire to prioritise those with severe ME, but I’m just not sure the extent of the impact of any exertion/stimulation on those with severe ME is being taken into account here.
It seems to me that it is very, very easy to make someone with severe or very severe ME worse. I think that health professionals often look at someone with severe or very severe ME and think, the only way is up, and that is just not the case.
There was mention above of doing sleep studies at the beginning and end of a, maybe, 6 month trial. That is far too much exertion to expect from people with severe/very severe ME. Of the subset who would be able to travel to hospital and do the sleep study for a night, I suspect that many would be wiped out for weeks/months. Some would have a long-term deterioration. You could alter the outcome of the trial just by PEM-ing the patients with a baseline sleep study.
If I was going to get severe or very severe patients to do anything, even fill out a brief form twice in 6 months, I’d really want to have a very good reason for thinking that it was going to benefit them. I don’t think we’re even close to that point.
If we clarified what was helpful for people with moderate ME, we’d have somewhere to start. It would be less risky; they’re a more robust group, but far from healthy.
The MEA’s 2010 survey is interesting regarding sleep (see p.17-18
https://www.meassociation.org.uk/wp-content/uploads/MEA-Management-Survey-2010.pdf. Results are probably more representative of the moderate-mild groups than of the ME population as a whole. 15% of respondents rated their “current state of health” as “severely” affected by their illness, 57% moderately and 28% mildly.
Respondents rated 5 therapies for sleep – 3 drugs, relaxation techniques and sleep hygiene advice.
Sleep hygiene advice came last in terms of those reporting a good or moderate effect: 36%. This compares poorly with the 58.1% who reported a good or moderate effect with short-acting sleeping tablets and the 57.8% who reported a good or moderate effect with relaxation techniques.
Most – 47.6% - reported no change with sleep hygiene advice.
Based on this survey (MEA 2010), the thing most worth looking at would be relaxation techniques or drugs.
Sleep was a priority for patients, the top priority, actually, of the 6 symptom areas that were asked about in the survey. 77.4% wanted help with sleep problems from the NHS, compared to, say, 47.6% for bowel symptoms.
So it seems like a trial around sleep management could be a good idea.